Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.
Gubra A/S
Gubra discovers peptide-based drugs and runs preclinical research studies for other pharma and biotech companies.
Gubra is a Danish biotech that does two related jobs under one roof. It runs a contract research business, where other drug companies pay it to test their experimental medicines in animals and lab models before those medicines ever reach human trials. And it runs its own drug discovery pipeline, building peptide drugs — short chains of amino acids — aimed at diseases like obesity and liver disease.
The contract research side is the steady, cash-generating engine. Gubra specializes in metabolic and liver disease models, and it has built a reputation as one of the go-to places for companies working on obesity and fatty liver drugs. That niche got a lot more crowded with customers after the weight-loss drug boom, since anyone developing a new obesity treatment needs solid preclinical data to show investors and regulators that their molecule is worth testing in people. The drug discovery side is the upside bet. Gubra develops its own peptide candidates and then partners them with larger companies, collecting upfront payments and milestone checks if the programs advance. Its most valuable asset is a long-acting amylin compound, which it licensed to Eli Lilly — a deal that turned a small Danish research shop into a company with real cash and a shot at milestone payments worth well over a billion dollars if the drug progresses.
That Lilly partnership is the clearest picture of how Gubra creates value: do the painstaking early science, then hand the promising molecule to a giant that can afford the enormous cost of late-stage trials. The risk is real, though. The contract research business depends on biotech spending, which dries up when funding gets tight, and the pipeline only pays off if the drugs actually work. Still, the combination gives Gubra two ways to win: steady fees today and lottery-ticket milestones tomorrow.
Saved answer · last researched 12 Nov 2026